Microbiome innovation is advancing across therapeutics, diagnostics, nutrition, cosmetics, agriculture, animal health, forensic science and environmental technologies. While often associated with bacteria, microbiomes also include fungi, viruses and other microorganisms that influence health, disease, productivity and sustainability.
Our microbiome patent attorneys help protect innovations involving probiotics, prebiotics, postbiotics, live biotherapeutics, biomarkers, microbial consortia, engineered microbes and bioinformatics platforms. We advise biotechnology companies, university spin-outs and research organisations on IP strategies for this technically complex and commercially fast-moving field.
Match me to a relevant specialist attorney
Rachel Mercer discusses how biological deposits can be used to fulfil the requirements of a sufficient disclosure for patent applications involving biological material.
Read more
CRISPR mediated gene editing technology is an efficient and highly selective technique that allows the DNA of organisms to be easily and precisely modified.
Read more
The Broad Institute of MIT and Harvard (‘Broad’) have won the latest round in the ongoing battle over patents relating to the gene editing technology, CRISPR.
Read more
What is CRISPR? Clustered regularly interspaced short palindromic repeats (CRISPRs) are a family of DNA sequences found in bacteria.
Read more
The Board of Appeal of the EPO dismissed the Broad Institute’s appeal against the Opposition Division’s previous decision to revoke one of their patents covering CRISPR gene editing technology (EP2771468) on 16 January 2020.
Read more
Senior Associate
BSc(Hon), MSc, PhD, CPA, EPA, MRSB
Edward has experience assisting a wide variety of biotechnology and medical device companies to protect their innovations. Edward’s time working in academia helps him understand the needs of universities and spin-outs, when commercialisin…
